NewsMarkets

Business

Novartis CEO Warns US Biotech Curbs on China Could Hamper Drug Development

Vas Narasimhan says proposed Treasury investment limits would hinder technology transfer between US and Chinese operations.

4 publishers · 5 articles · first seen 18 Nov 2026 · updated 21h ago

Headline and summary written by an AI model from the linked articles; not reviewed by a person. How this was made

The odds

How the odds moved · By 2030
0%50%100%21%19 Nov, 17:45 UTCnowBloomberg Technology: Novartis CEO Says US China Biotech Curbs Risk Drug Development · 20 Nov, 13:43 UTCQuartz: Novartis CEO warned U.S. biotech curbs on China could slow drug development · 20 Nov, 14:50 UTCSouth China Morning Post: US panel warns of China’s biotech rise, fuelling push to curb ties as Chinese firms unfazed · 19 Nov, 23:00 UTC

Each tick is a source publishing on this story · 2 more published before price tracking began

Price data
TimeChance of yes
now21%
19 Nov, 17:45 UTC21%

The story so far

4 publishers have covered this in 5 articles since 18 Nov 2026. South China Morning Post published first, on 18 November at 08:00 UTC; STAT followed 33h 05m later. The most recent article, from Quartz, appeared on 20 November at 14:50 UTC.

Outlets reporting it: Bloomberg Technology (major outlet), South China Morning Post, STAT, Quartz.

One prediction market prices this story:

  • By 2030 — the market puts it at 21%, closing 1 Jan 2030. The market resolves to Yes if China's gross domestic product exceeds that of the United States by the year 2030. It resolves to No if China's GDP does not surpass the US total within that timeframe. Readers often mistake the linked news story about rare earth processing for the actual resolution criteria, but only GDP figures determine the outcome.

Odds are the market's probability that the outcome happens, updated every few minutes. They are information about what traders expect, not a forecast we make and not investment advice.

Sources

Every article we clustered into this story. Headlines link to the publisher.

  1. Novartis CEO Says US China Biotech Curbs Risk Drug Development Bloomberg Technology ·
  2. Novartis CEO warned U.S. biotech curbs on China could slow drug development Quartz
  3. US panel warns of China’s biotech rise, fuelling push to curb ties as Chinese firms unfazed South China Morning Post
  4. STAT+: Lawmakers want U.S. biotech to outcompete China STAT
  5. China still has ‘catching up to do’ to become biotech powerhouse, JPMorgan says South China Morning Post

Related prediction markets

Linked by software because they are about the same subject. Most ask a different question from the one this story reports, so read each market's own question. How often the link is right

  • Kalshi By 2030 · China overtakes USA’s economy by 2030? 21% $0 24hends 1 Jan 2030

    Does the market have this right?

    Wrong market?

Have your say

Your call. How does this end?

Free, no money involved. Calls are scored against the market's price when you make them, so backing an underdog that wins scores most. Leaderboard · Your calls

Alert me when the odds move

Email: we send a link to confirm first, and you can unsubscribe in one click. Browser notifications need no email and are turned off on the Following page. At most one alert every six hours either way. Privacy

In this story

  • Novartis
  • Vas Narasimhan
  • US-China Economic and Security Review Commission
  • JPMorgan
Embed this story

Paste this into any web page to show the live odds, with a link back here.